Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation
- PMID: 15616337
- PMCID: PMC538854
- DOI: 10.1128/AAC.49.1.461-463.2005
Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation
Abstract
A Monte Carlo simulation demonstrated that 1 g of meropenem (MEM) every 8 h (q8h) (3-h infusion) has a higher target attainment rate against Pseudomonas aeruginosa than either 500 mg of MEM q8h (3-h infusion) or 0.5 g of imipenem-cilastatin (I-C) q6h (1-h infusion). For other pathogens, 500 mg of MEM q8h was equivalent or superior to I-C.
References
-
- Bauernfeind, A., and F. Sörgel. 1997. Comparative bactericidal effect of discontinuous vs. continuous dosing of meropenem in a pharmacodynamic model, abstr. A36. Abstr. 37th Intersci. Conf. Antimicrob. Agents Chemother., 28 September to 1 October, Toronto, Ontario, Canada.
-
- Craig, W. A., S. Ebert, and Y. Watanabe. 1993. Differences in time above MIC (T>MIC) required for efficacy of beta-lactams in animal infection models, abstr. 86. Program Abstr. 33rd Intersci. Conf. Antimicrob. Agents Chemother., New Orleans, La.
-
- D'Argenio, D. Z., and A. Schumitzky. ADAPT II user's guide. University of Southern California, Los Angeles.
-
- Domenig, C., F. Traunmuller, S. Kozek, W. Wisser, W. Klepetko, et al. 2001. Continuous beta-lactam antibiotic therapy in a double-lung transplanted patient with a multidrug-resistant Pseudomonas aeruginosa infection. Transplantation 71:744-745. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources